Active substance
Solifenacin
- SFDA 24
- US FDA 28
- Health Canada 24
- US price lines 2
- NHS prices 4
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Dergit | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | Savvy Pharma | Valid |
| Dergit | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | Savvy Pharma | Valid |
| FENSOLIN 10 mg Film Coated Tablet | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| FENSOLIN 5 mg Film Coated Tablet | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| KINZY | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | Abdi Ibrahim Ilac San ve Tic A.S. | Valid |
| KINZY | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | Abdi Ibrahim Ilac San ve Tic A.S. | Valid |
| LIFANCE 10MG F.C.TABLET | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| LIFANCE 5MG F.C.TABLET | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| SOLFISAN 10 mg Film Coated Tablet | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 121.00 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
| SOLFISAN 5 mg Film Coated Tablet | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 94.10 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
| Solifenacin Succinate ALH | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | Alhobail Pharm | Valid |
| Solifenacin succinate ALH | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | Alhobail Pharm | Valid |
| Solitrol | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | Apex Pharma | Valid |
| Solitrol | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | Apex Pharma | Valid |
| URILAX 10MG FILM COATED TABLET | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 149.40 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| URILAX 5MG FILM COATED TABLET | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 116.15 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| Uroleph | 10 mg | Film-coated tablet · Oral use | 28 Blister | SAR 101.65 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| Uroleph | 5 mg | Film-coated tablet · Oral use | 28 Blister | SAR 79.05 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| VESICARE 10 mg film-coated tablet | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 174.70 | NCE · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Valid |
| VESICARE 5 mg film-coated tablet | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 135.85 | NCE · Prescription | SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO | Valid |
| Veslo | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 84.70 | Generic · Prescription | SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| Veslo | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 108.90 | Generic · Prescription | SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| KINZY 10 mg Film Coated Tablet | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 134.45 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Withdrawn by regulatory authority · Not Marketed |
| KINZY 5 mg Film Coated Tablet | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 104.55 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Withdrawn by regulatory authority · Not Marketed |
Indications — CHI Daman Drug Formulary
BENIGN PROSTATIC HYPERTROPHY; NOCTURNAL ENURESIS; URINARY INCONTINENCE AND OVERACTIVE BLADDER
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | TEVA PHARMS USA | Prescription | 2 Apr 2014 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | WATSON LABS INC | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | ALEMBIC | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | GLENMARK SPECLT | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | QILU | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | ALKEM LABS LTD | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | BOSTAL | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | CHARTWELL RX | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | MSN | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | SCIEGEN PHARMS | Prescription | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | UNICHEM | Prescription | 27 Aug 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | NOVITIUM PHARMA | Prescription | 26 Sep 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | RISING | Prescription | 11 Dec 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | SUNSHINE | Prescription | 13 Apr 2020 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | ANNORA PHARMA | Prescription | 15 Jun 2022 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | AUROBINDO PHARMA | Prescription | 27 Dec 2022 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | MACLEODS PHARMS | Prescription | 20 Feb 2024 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | JUBILANT GENERICS | Prescription | 2 Oct 2024 |
| VESICARE | 5MG; 10MG | tablet · oral | ASTELLAS | Discontinued | 19 Nov 2004 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | AJANTA PHARMA LTD | Discontinued | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | AMNEAL PHARMS CO | Discontinued | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | BRECKENRIDGE | Discontinued | 20 May 2019 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | CIPLA | Discontinued | 20 May 2019 |
| VESICARE LS | 1MG/ML | suspension · oral | ASTELLAS | Discontinued | 26 May 2020 |
| SOLIFENACIN SUCCINATE | 5MG; 10MG | tablet · oral | ZYDUS PHARMS | Discontinued | 19 Oct 2020 |
3 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACH-SOLIFENACIN SUCCINATE | 02439344 | 5 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| ACH-SOLIFENACIN SUCCINATE | 02439352 | 10 MG | TABLET · ORAL | ACCORD HEALTHCARE INC |
| AURO-SOLIFENACIN | 02446375 | 5 MG | TABLET · ORAL | AURO PHARMA INC |
| AURO-SOLIFENACIN | 02446383 | 10 MG | TABLET · ORAL | AURO PHARMA INC |
| BIO-SOLIFENACIN | 02516519 | 5 MG | TABLET · ORAL | BIOMED PHARMA |
| BIO-SOLIFENACIN | 02516527 | 10 MG | TABLET · ORAL | BIOMED PHARMA |
| JAMP SOLIFENACIN SUCCINATE | 02428911 | 5 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP SOLIFENACIN SUCCINATE | 02428938 | 10 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| PMS-SOLIFENACIN | 02417723 | 5 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-SOLIFENACIN | 02417731 | 10 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PRZ-SOLIFENACIN | 02493039 | 5 MG | TABLET · ORAL | PHARMARIS CANADA INC |
| PRZ-SOLIFENACIN | 02493047 | 10 MG | TABLET · ORAL | PHARMARIS CANADA INC |
| SANDOZ SOLIFENACIN | 02399032 | 5 MG | TABLET · ORAL | SANDOZ CANADA INCORPORATED |
| SANDOZ SOLIFENACIN | 02399040 | 10 MG | TABLET · ORAL | SANDOZ CANADA INCORPORATED |
| SOLIFENACIN | 02458144 | 5 MG | TABLET · ORAL | PRO DOC LIMITEE |
| SOLIFENACIN | 02458152 | 10 MG | TABLET · ORAL | PRO DOC LIMITEE |
| SOLIFENACIN | 02458241 | 5 MG | TABLET · ORAL | SANIS HEALTH INC |
| SOLIFENACIN | 02458268 | 10 MG | TABLET · ORAL | SANIS HEALTH INC |
| TARO-SOLIFENACIN | 02437988 | 5 MG | TABLET · ORAL | SUN PHARMA CANADA INC |
| TARO-SOLIFENACIN | 02437996 | 10 MG | TABLET · ORAL | SUN PHARMA CANADA INC |
| TEVA-SOLIFENACIN | 02397900 | 5 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-SOLIFENACIN | 02397919 | 10 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| VESICARE | 02277263 | 5 MG | TABLET · ORAL | ASTELLAS PHARMA CANADA INC |
| VESICARE | 02277271 | 10 MG | TABLET · ORAL | ASTELLAS PHARMA CANADA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | SOLIFENACIN 10 MG TABLET | $0.16167 | per EA | 30 Sep 2026 |
| US NADAC | SOLIFENACIN 5 MG TABLET | $0.14134 | per EA | 30 Sep 2026 |
| NHS Drug Tariff | Solifenacin 10mg tablets | £1.20 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Solifenacin 1mg/ml oral suspension sugar free | £27.62 | 150 ml | 1 Oct 2026 |
| NHS Drug Tariff | Solifenacin 5mg tablets | £1.04 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Solifenacin 5mg/5ml oral solution sugar free | £182.53 | 150 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 26 May 2020 VESICARE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Solifenacin
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.